Ra Medical Systems focuses on commercializing excimer lasers and catheters for its immense contribution in the treatment of vascular and dermatological diseases. The Dabra excimer in May 2017, received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions. The pharos excimer laser system is also FDA-cleared and is an important tool in treating psoriasis, vitiligo, atopic dermatitis , and leukoderma. Located in a 32,000 square foot facility at Carlsbad, California, DABRA and Pharos excimer lasers and catheters are all based on Ra Medical’s core excimer technology and perform similar actions. The vertically integrated facility also has an ISO 13485 certification.